BFLY vs CBLL vs NNOX Stock Comparison

Butterfly Network, Ceribell and Nano-X Imaging Prices as of Oct 27, 2026 Peers: Industry group
BFLY Butterfly Network, Inc.
$7.40 -21.2% 1M +236.4% 1Y
Market cap
$2.05B
P/E
–
Revenue (TTM)
$112.15M
Div. yield
–
Diagnostic Equipment Healthcare
4 wins
CBLL Ceribell, Inc.
$27.22 +14.9% 1M +111.2% 1Y
Market cap
$1.04B
P/E
–
Revenue (TTM)
$101.96M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
NNOX Nano-X Imaging Ltd.
$0.32 -50.0% 1M -92.1% 1Y
Market cap
$20.72M
P/E
–
Revenue (TTM)
$15.63M
Div. yield
–
Diagnostic Equipment Healthcare
1 win

Head to Head

8 decided of 12

Butterfly Network leads on 4 of the 12 questions below (Butterfly Network 4, Ceribell 3, Nano-X Imaging 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYCBLLNNOXLeader
Larger companyMarket capitalisation $2.05B $1.04B $20.72M BFLY
Cheaper on earningsLower P/E, profitable companies only -27.4x -15.8x -0.2x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months +28.1% +31.7% +31.5% CBLL
More profitableNet margin, trailing twelve months -66.7% -64.7% -747.2% CBLL
Better return on capitalReturn on invested capital — — -116.9% –
Less leveragedLower net debt / EBITDA — 1.6x 0.3x NNOX
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +236.4% +111.2% -92.1% BFLY
Better 5-year returnAnnualised price return, 5 years -6.3%/yr — -57.4%/yr BFLY
Less volatileAnnualised volatility, 1 year 114.8% 52.1% 105.8% CBLL
Higher overall scoreMean of the five percentile scores vs peers 45/100 38/100 36/100 BFLY

Percentile Scorecard

BFLYCBLLNNOX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYCBLLNNOX
Valuation 28 #164 of 227 22 #178 of 227 54 #105 of 227
Growth 68 #71 of 219 22 #172 of 219 10 #198 of 219
Profitability 32 #140 of 206 38 #129 of 206 10 #185 of 206
Financial Health 61 #94 of 238 81 #46 of 238 71 #71 of 238
Shareholder Returns 37 #85 of 134 30 #94 of 134 –
Overall 45 38 36
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • CBLL ranked among 247 companies in Medical Devices and Diagnostics
  • NNOX ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYCBLLNNOXSPY
1 month -21.2%+14.9%-50.0% -0.2%
3 months +3.1%+52.7%-63.6% +3.9%
6 months +43.4%+30.9%-82.2% +8.2%
Year to date +94.7%+24.1%-88.6% +12.9%
1 year +236.4%+111.2%-92.1% +12.3%
3 years +836.7%—-93.6% +87.4%
3 years, per year +110.9%—-60.1% +23.3%
5 years -27.6%—-98.6% +67.9%
5 years, per year -6.3%—-57.4% +10.9%

Risk

MeasureBFLYCBLLNNOXSPY
Volatility, 1Y 114.8%52.1%105.8% 12.7%
Downside volatility, 1Y 91.7%49.5%116.3% 12.7%
Beta vs S&P 500, 1Y 3.001.211.36 1.00
Return / volatility, 1Y 2.062.13-0.87 0.97
Max drawdown, 5Y -93.4%-63.9%-98.8% -25.4%
From 52-week high -25.6%-1.7%-93.0% -1.2%
52-week high $9.94$27.68$4.55 $779.14
52-week low $1.97$10.92$0.32 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYCBLLNNOX
P/E now vs peer median -25.9xmedian 29.6x -15.7xmedian 29.6x -0.2xmedian 29.6x
P/S now vs peer median 15.7xmedian 2.9x 10.2xmedian 2.9x 1.4xmedian 2.9x
EV/EBITDA now vs peer median -22.6xmedian 17.4x -13.6xmedian 17.4x 0.1xmedian 17.4x
P/FCF now vs peer median -62.8xmedian 22.3x -19.0xmedian 22.3x -0.4xmedian 22.3x
P/B now vs peer median 9.3xmedian 2.3x 8.1xmedian 2.3x 0.3xmedian 2.3x
PEG now vs peer median -0.96median 1.04 —median 1.04 -0.08median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYCBLLNNOX
Revenue $112.15M $101.96M $15.63M
Gross profit $59.04M $90.65M -$52.76M
Operating income -$79.38M -$69.97M -$119.69M
Net income -$74.85M -$66.00M -$116.81M
Free cash flow -$28.04M -$54.72M -$52.09M
R&D $38.10M $22.95M $18.93M
EPS (diluted) $-0.29 $-1.74 $-1.80
Cash & equivalents $124.66M $32.66M $31.02M
Total debt – $19.98M $12.50M
Shares (diluted) 262.10M 38.03M 64.79M
Enterprise value $1.49B $443.26M -$158.95M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYCBLLNNOX
P/E -25.9x -15.7x -0.2x
P/FCF -62.8x -19.0x -0.4x
P/Operating cash flow -73.3x -19.3x -0.5x
P/S 15.7x 10.2x 1.4x
P/B 9.3x 8.1x 0.3x
P/Tangible book 9.6x 8.1x 0.4x
EV/EBITDA -22.6x -13.6x 0.1x
EV/EBIT -20.6x -13.3x 0.0x
EV/Revenue 14.6x 9.1x -0.4x
EV/FCF -58.4x -17.0x 0.1x
EV/Operating cash flow -68.1x -17.2x 0.1x
PEG (3Y EPS CAGR) -0.96 – -0.08

Growth

14 metrics
MetricBFLYCBLLNNOX
Revenue growth (1Y) 28.1% 31.7% 31.5%
Revenue CAGR (3Y) 15.6% – 17.7%
Gross profit growth (1Y) 8.8% 33.4% -340.0%
Gross profit CAGR (3Y) 13.3% – -101.8%
Operating income growth (1Y) -14.8% -34.6% -107.4%
Operating income CAGR (3Y) 21.1% – -5.0%
Net income growth (1Y) -19.1% -33.6% -109.9%
Net income CAGR (3Y) 20.8% – -4.9%
EPS growth (1Y) -12.9% -27.5% -90.0%
EPS CAGR (3Y) 27.0% – 2.3%
Operating cash flow growth (1Y) 19.6% -44.3% -21.9%
Operating cash flow CAGR (3Y) 44.5% – -2.7%
Free cash flow growth (1Y) 12.2% -41.8% -19.4%
Free cash flow CAGR (3Y) 42.8% – 1.3%

Profitability

14 metrics
MetricBFLYCBLLNNOX
Gross margin 52.6% 88.9% -337.5%
EBITDA margin -64.4% -67.1% -692.4%
Operating margin -70.8% -68.6% -765.6%
Pretax margin -66.7% -64.7% -758.5%
Net margin -66.7% -64.7% -747.2%
FCF margin -25.0% -53.7% -333.2%
Operating cash flow margin -21.4% -53.0% -298.7%
Return on equity -39.3% -49.0% -117.5%
Return on assets -26.3% -38.3% -98.6%
Return on invested capital – – -116.9%
Return on capital employed -35.1% -45.1% -114.2%
Asset turnover 0.4x 0.6x 0.1x
Cash conversion (OCF / net income) 0.3x 0.8x 0.4x
Stock comp / revenue 21.3% 16.1% 34.9%

Financial Health

11 metrics
MetricBFLYCBLLNNOX
Debt / assets – 12.0% 3.3%
Debt / equity – 0.2x 0.0x
Net debt / EBITDA – 1.6x 0.3x
Debt / FCF – -0.4x -0.1x
Liabilities / assets 33.1% 22.9% 20.5%
Equity / assets 66.9% 77.1% 79.5%
Interest coverage -59.4x -38.6x –
Current ratio 4.1x 9.2x 2.8x
Quick ratio 2.7x 8.6x 2.4x
Cash ratio 2.1x 7.5x 2.3x
Altman Z-score 7.05 14.47 -11.07

Shareholder Returns

7 metrics
MetricBFLYCBLLNNOX
Dividend yield – – –
Net buyback yield -0.4% -0.6% –
Shareholder yield -0.4% -0.6% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYCBLLNNOX
EPS, next fiscal year $-0.10FY2026 $-1.86FY2026 $-1.31FY2026
Revenue, next fiscal year $114.50MFY2026 $118.32MFY2026 $18.64MFY2026
Revenue growth, next FY +17.3%FY2026 +32.9%FY2026 +43.2%FY2026
Revenue growth, the year after +26.0% +21.1% +59.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYCBLLNNOX
Held by institutions 59.9% 79.9% 14.9%
Institutions holding 245 124 102
Change in shares held, QoQ +13.9% +2.2% -46.0%
Institutions buying 143 74 55
Institutions selling 59 36 28
Buyers to sellers 2.42 2.06 1.96

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYCBLLNNOX
BFLY 1.00 0.37 0.16
CBLL 0.37 1.00 0.14
NNOX 0.16 0.14 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, CBLL and NNOX?

Butterfly Network (BFLY) is the largest by market capitalisation: Butterfly Network (BFLY) $2.05B, Ceribell (CBLL) $1.04B, Nano-X Imaging (NNOX) $20.72M.

Which company is growing faster?

Ceribell (CBLL) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +28.1%, Ceribell (CBLL) +31.7%, Nano-X Imaging (NNOX) +31.5%.

Which company is more profitable?

Ceribell (CBLL) has the highest net margin (Butterfly Network (BFLY) -66.7%, Ceribell (CBLL) -64.7%, Nano-X Imaging (NNOX) -747.2%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +236.4%, Ceribell (CBLL) +111.2%, Nano-X Imaging (NNOX) -92.1%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -6.3%/yr, Nano-X Imaging (NNOX) -57.4%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Ceribell (CBLL) has been the steadiest (Butterfly Network (BFLY) 114.8%, Ceribell (CBLL) 52.1%, Nano-X Imaging (NNOX) 105.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, CBLL and NNOX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.